North America Health Investment Group announces an agreement to provide GMP consulting services to Shandong Buchang Pharmaceuticals Co., Ltd.

North America Health Investment Group (NAH) announces an agreement to provide Canadian site and product GMP consulting services to Shandong Buchang Pharmaceuticals Co., Ltd. (Buchang) (山东步长制药股份有限公司). This partnership is developed over five years discussion on the best way to demonstrate the quality traditional medicines of Buchang. In this partnership agreement, NAH will provide Buchang with expert Canadian GMP site and product licensing services for all Traditional Chinese Medicine manufacture sites under Buchang and a large number of their Traditional Medicines.

The agreement duration is expected to be 18 to 24 months long, and designed to establish recognition of safety, efficacy and quality of the traditional medicines manufactured by Buchang. It will further strengthen Bucheng’s leading position in Traditional Chinese Medicine manufacturing in China and in North America.

North America Health Investment Group Inc. provides management and Natural Health Products consulting to some of the leading herbal medicine manufacturers around the world. One of the expert services of the company is in Traditional Chinese Medicine quality management and Canadian Licensing. North America Health customers include some of the largest pharmaceutical manufacturers in China.

Buchang Pharmaceuticals is a China’s well-known enterprise which specializes in the R&D, production and sale of TCM patent medicines. The Company has set up its production bases in Shandong, Shaanxi, Hebei and the Northeast China, with its marketing network spreading all over major provinces of China. The Company was honored the titles of “Honest Taxpaying Enterprise”, “Assured Pharmaceutical Enterprise among People”, “China’s Top10 Best Pharmaceutical Enterprises”, etc. Danhong injection was awarded “Gold Medal for China’s first TCM Patent”; “Buchang Naoxintong” was honored the title of “Top 10 Best TCM Product Brands”. In 2013, Buchang received the honor as “2013 China Five-star Corporate Citizen”. In 2014, Buchang Pharmaceuticals won the “2014 Special Contribution Prize for the Chinese Philanthropy”. In 2015, Buchang Pharmaceuticals was honored the title of “Best Industrial Enterprise in Chinese Pharmaceutical R&D Production Lines of 2015”.

Leave a Reply

Your email address will not be published. Required fields are marked *